 |
| MJNA Sub in the Spotlight at Natural Products Expo East |
|
 Hot Stock to Watch
|
Company: Medical Marijuana Inc. (Pink Sheets: MJNA)
|
End of Day:
Price: 0.158
Change (%): + 0.0001 (0.06)
Volume: 15,958,766 |
 |
HempMedsPX to Showcase Hemp Cannabidiol Products From Medical Marijuana Inc. at Natural Products Expo East
HempMedsPX is Gold Sponsor of East Coast’s Largest Natural and Organic Products Trade Show
SAN DIEGO, Sept. 3, 2013 (GLOBE NEWSWIRE) - Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX-a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana Inc.- will be representing both MJNA and US Hemp Oil as Gold Sponsor of Natural Products Expo East in Baltimore, MD from September 25-28, 2013.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Essential Innovations Technology Corp. (OTCQB: ESIV)
|
End of Day:
Price: 0.07
Change (%): + 0.0175 (33.33)
Volume: 59,120 |
 |
Essential Innovations is driven to provide eco-friendly lifestyle enhancement solutions for the betterment of energy, water, air and health. The Company holds the exclusive global manufacturing, distribution and applications rights to the ‘Eximius Technologies - Extraordinary solutions for an ever-changing World'. The Company is recognized around the World as a leader in the deployment of comprehensive, customized, renewable energy and environmental solutions with particular emphasis given to the application of water source and/or geothermal heat pump technology. The Company has the resources and direct relationships in place globally to take projects of solar, wind, geothermal, waste and bio-fuel sources, water treatment/purification or desalination of most any size and scope from vision to reality.
Company Information Sheet |
Other Small Cap News
|
Company: Axxess Pharma Inc. (Pink Sheets: AXXE)
|
Axxess Pharma Inc. Announces US Board Certified Cardiologist, Dr. Fred Maese as Senior Consultant
Dr. Maese Brings Forth Strong Medical Following via His Established Radio Shows
TORONTO, ON--(Marketwired - Sep 4, 2013) - Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce Dr. Fred Maese, US Board-Certified Cardiologist and a member of the American College of Cardiology, has joined Axxess Pharma.
Since 1997 Dr. Maese has been practicing adult Cardiology and Internal Medicine in Dallas, Texas with expertise in general clinical cardiology, echocardiography and nuclear cardiology. Dr. Maese also has a large following on his radio shows, which cross over to the Hispanic network 'Univision.'
Continue Reading
|
Company: Plandaí Biotechnology, Inc. (OTCQB: PLPL)
|
Plandai Biotechnology, Inc. Announces Completion of Production Facility, Installation of Equipment to Commence
SEATTLE, WA--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today provided updated information on the status of the Company's operations, specifically addressing the manufacturing facility in South Africa, status of clinical trials, and expectation for commencing sales.
Roger Duffield, Chairman and Chief Executive Officer of Plandaí Biotechnology, stated, "As a company, we're excited to announce that our subsidiary, Green Gold Biotechnologies, has completed its state-of-the-art production facility in Mpumalanga, South Africa, in the heart of our tea estate. The unique processing and extraction system we employ to ensure that our products are highly bioavailable requires that we use only live plant material. We are therefore constrained to have our factory onsite, enabling processing to commence within an hour of harvest.
Continue Reading |
Market News
|
By Mike Dolan: Reuters
|
Analysis: Sober summer markets may defuse September strife
(Reuters) - Investors have been braced for a stormy September for so long now it's getting difficult to see this month's stiffening gales blowing them off course for long.
September - traditionally the worst month of the year for U.S. stocks with an average loss since 1928 of 1.1 percent - does look rough again. It's just a wonder who's left to surprise.
Even a cursory glance at event diaries during the Spring would already have given fair warning of what the final month of the third quarter was brewing.
Continue Reading
|
By Namitha Jagadeesh: Bloomberg
|
U.S. Stocks Rise Before Syria Vote, Economic Reports
U.S. stocks rose, extending a one-week high, before a Senate committee vote on action against Syria as investors awaited economic data for clues on the Federal Reserve’s next move.
Apple Inc. advanced 2.2 percent after Cantor Fitzgerald LP initiated coverage of the shares with a 12-month price estimate that is 59 percent higher than yesterday’s close. LinkedIn Corp. lost 1.7 percent in early New York trading after saying it will sell shares for about 1 billion dollars. Microsoft Corp. fell as Morgan Stanley lowered its rating of the software maker after its deal to buy Nokia Oyj’s devices unit.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
